Business
Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development
(TheNewswire) Calgary, Alberta, Canada – TheNewswire - March 13, 2024 - ...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development \n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Calgary, Alberta, Canada –\n \n \n TheNewswire -\n \n \n March 13, 2024 -\n \n \n Voyageur Pharmaceuticals\nLtd\n \n \n . (\n \n \n TSX.V: VM\n \n \n ) (USA: VYYRF) (\"Voyageur\"\nor the \"Corporation\"), announces a significant advancement\nin its partnership with Rain Cage Carbon Inc. (\"Rain Cage\").\nThis milestone signifies the execution of a royalty agreement that\nsolidifies the exclusive development and license agreement between the\nparties and it further reinforces Voyageur’s commitment to\npioneering sustainable carbon drug development.\n \n \n \n \n Brent Willis, CEO of Voyageur states, “Voyageur is\npioneering the development of the world's first carbon-neutral\npharmaceutical company. Our groundbreaking carbon drug program may\nrevolutionize the industry, by harnessing captured CO\n \n \n 2\n \n \n as its primary ingredient. This\ninnovative approach not only aligns with sustainable practices but\nalso positions Voyageur as a trailblazer in the radiology drug market\nthrough seamless vertical integration. Our Rain Cage partnership is\nshaping the future of environmentally conscious and cutting-edge\npharmaceutical solutions.”\n \n \n \n \n Driving Innovation in Healthcare\nImaging\n \n \n \n \n Voyageur and Rain Cage have solidified their strategic\nalliance and are poised to redefine healthcare imaging technologies.\nThe execution of the royalty agreement underscores their shared\ndedication to leveraging Rain Cage's pioneering EDEN™ carbon capture\ntechnology for the creation of innovative nanocarbon/fullerene-based\nimaging drugs.\n \n \n \n \n Building an Eco-Friendly Drug\nPipeline\n \n \n \n \n In alignment with its sustainable goals, Voyageur is\nforging ahead with the establishment of an eco-friendly drug pipeline.\nThis pipeline includes barium sulfate contrast media, iodinated\ncontrast media, and carbon contrast media products, forming an\nintegral part of Voyageur's Earth to Bottle strategic business\nplan.\n \n \n \n \n Pioneering MRI Drug\nDevelopment\n \n \n \n \n With a focus on innovation, Voyageur is spearheading\nthe development of a new MRI drug ...